Post-translational Modification of Fibroblast Growth Factor 23
- 19 July 2005
- journal article
- review article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 9 (4), 319-322
- https://doi.org/10.1111/j.1744-9987.2005.00289.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemiaHuman Molecular Genetics, 2004
- FGF23 is processed by proprotein convertases but not by PHEXBone, 2004
- Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosisNature Genetics, 2004
- Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEXJournal of Biological Chemistry, 2003
- Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked HypophosphatemiaNew England Journal of Medicine, 2003
- Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice.Journal of Clinical Investigation, 1997
- A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic ricketsNature Genetics, 1995
- Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroidNature, 1993
- Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect.Journal of Clinical Investigation, 1992
- Renal transplantation in hypophosphatemia with vitamin D-resistant ricketsArchives of Internal Medicine, 1974